Načítá se...
Efficacy of nebivolol‐valsartan single‐pill combination in obese and nonobese patients with hypertension
Antihypertensive efficacy of single‐pill combinations (SPCs) consisting of a β(1)‐selective adrenergic blocker with vasodilatory properties via β(3)‐agonism (nebivolol) and an angiotensin II receptor blocker (valsartan) was demonstrated in an 8‐week phase 3 trial (NCT01508026). In this post hoc anal...
Uloženo v:
| Vydáno v: | J Clin Hypertens (Greenwich) |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5484387/ https://ncbi.nlm.nih.gov/pubmed/28075064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12965 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|